{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T11:37:43Z","timestamp":1791373063458,"version":"4.3.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2001,8,1]],"date-time":"2001-08-01T00:00:00Z","timestamp":996624000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2001,8]]},"DOI":"10.1007\/s10434-001-0580-9","type":"journal-article","created":{"date-parts":[[2005,2,26]],"date-time":"2005-02-26T02:23:20Z","timestamp":1109384600000},"page":"580-585","source":"Crossref","is-referenced-by-count":163,"title":["Patient Reluctance Toward Tamoxifen Use for Breast Cancer Primary Prevention"],"prefix":"10.1007","volume":"8","author":[{"given":"Elisa Rush","family":"Port","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie L.","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra S.","family":"Heerdt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick I.","family":"Borgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/canjclin.50.1.7","volume":"50","author":"RT Greenlee","year":"2000","unstructured":"Greenlee RT, Murray T, Bolden S, Wingo P. Cancer statistics, 2000.2 CA Cancer J Clin 2000; 50: 7?33.","journal-title":"2 CA Cancer J Clin"},{"key":"CR2","first-page":"47","volume-title":"Breast Cancer","author":"DV Spicer","year":"1999","unstructured":"Spicer DV, Pike MC. Risk factors.In: Roses DF, ed. Breast Cancer. Philadelphia: Churchill Livingstone, 1999: 47?54."},{"key":"CR3","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0140-6736(97)11423-4","volume":"351","author":"Early Breast Cancer Trialists? Collaborative Group","year":"1998","unstructured":"Early Breast Cancer Trialists? Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomized trials. Lancet 1998; 351: 1451?67.","journal-title":"Lancet"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1200\/JCO.1996.14.1.103","volume":"14","author":"J Benichou","year":"1996","unstructured":"Benichou J, Gail MH, Mulvihill JJ. Graphs to estimate an individualized risk of breast cancer. J Clin Oncol 1996; 14: 103?10.","journal-title":"J Clin Oncol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","volume":"90","author":"B Fisher","year":"1998","unstructured":"Fisher B, Constantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998; 90: 1371?88.","journal-title":"J Natl Cancer Inst"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/jnci\/91.21.1829","volume":"91","author":"MH Gail","year":"1999","unstructured":"Gail MH, Costantino JP, Bryant J, et al. Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer. J Natl Cancer Inst 1999; 91: 1829?46.","journal-title":"J Natl Cancer Inst"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1093\/jnci\/91.19.1654","volume":"91","author":"L Bernstein","year":"1999","unstructured":"Bernstein L, Deapen D, Cerhan JR, et al. Tamoxifen therapy for breast cancer and endometrial cancer risk. J Natl Cancer Inst 1999; 91: 1654?62.","journal-title":"J Natl Cancer Inst"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0140-6736(98)85011-3","volume":"352","author":"U Veronesi","year":"1998","unstructured":"Veronesi U, Maisonneuve P, Costa A, et al. Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomized trial among hysterectomized women. Lancet 1998; 352: 93?7.","journal-title":"Lancet"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0140-6736(98)85012-5","volume":"352","author":"T Powles","year":"1998","unstructured":"Powles T, Eeles R Ashley S, et al. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial. Lancet 1998; 352: 98?101.","journal-title":"Lancet"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/S0738-3991(97)00095-5","volume":"32","author":"LM Osman","year":"1997","unstructured":"Osman LM. How do patients? views about medication affect their self-management in asthma? Patient Educ Couns 1997; 32: S43?9.","journal-title":"Patient Educ Couns"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"S252","DOI":"10.1016\/S0002-8703(99)70318-2","volume":"138","author":"GT McInnes","year":"1999","unstructured":"McInnes GT. Integrated approaches to management of hypertension: promoting treatment acceptance. Am Heart J 1999; 138: S252?5.","journal-title":"Am Heart J"},{"key":"CR12","first-page":"13","volume":"6","author":"VR Grann","year":"2000","unstructured":"Grann VR, Jacobson JS, Whang W, et al. Prevention with tamoxifen or other hormones versus prophylactic surgery in BRCA1\/2-positive women: a decision analysis. Cancer J Sci Am 2000; 6: 13?20.","journal-title":"Cancer J Sci Am"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0959-8049(98)00248-2","volume":"34","author":"P Osin","year":"1998","unstructured":"Osin P, Gusterson BA, Philp E, et al. Predicted anti-oestrogen resistance in BRCA-associated familial breast cancers. Eur J Cancer 1998; 34: 1683?6.","journal-title":"Eur J Cancer"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/S0140-6736(00)03258-X","volume":"356","author":"SA Narod","year":"2000","unstructured":"Narod SA, Brunet JS, Ghadirian P, et al. Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group. Lancet 2000; 356: 1876?81.","journal-title":"Lancet"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/106002808101500102","volume":"15","author":"JT McKenney","year":"1981","unstructured":"McKenney JT. Methods of modifying compliance behavior in hypertensive patients. Drug Intell Clin Pharm 1981; 15: 8?14.","journal-title":"Drug Intell Clin Pharm"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2337\/diacare.20.3.292","volume":"20","author":"LM Hunt","year":"1997","unstructured":"Hunt LM, Valenzuela MA, Pugh JA. NIDDM patients? fears and hopes about insulin therapy, the basis of patient reluctance. Diabetes Care 1997; 20: 292?8.","journal-title":"Diabetes Care"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1001\/jama.281.23.2189","volume":"281","author":"SR Cummings","year":"1999","unstructured":"Cummings SR, Eckert S, Krueger KA, et al. The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation. JAMA 1999; 281: 2189?97.","journal-title":"JAMA"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10434-001-0580-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10434-001-0580-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10434-001-0580-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T16:51:04Z","timestamp":1559148664000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10434-001-0580-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8]]},"references-count":17,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2001,8]]}},"alternative-id":["580"],"URL":"https:\/\/doi.org\/10.1007\/s10434-001-0580-9","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,8]]}}}